Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Makris, F. Preston, D. Triger, J. Underwood, Q. Choo, G. Kuo, M. Houghton (1990)
Hepatitis C antibody and chronic liver disease in haemophiliaThe Lancet, 335
H. Hsu, T. Wright, D. Luba, Mary Martin, S. Feinstone, G. Garcia, H. Greenberg (1991)
Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reactionHepatology, 14
Plasma Derivatives Laboratory, Division of Hematology
G. Kuo, Q. Choo, H. Alter, G. Gitnick, A. Redeker, R. Purcell, T. Miyamura, J. Dienstag, M. Alter, C. Stevens (1990)
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.Science, 244 4902
(1990)
sccond-gcncration assays
(1990)
Hepatitis C quantitation and sequencing in blood products, haemophiliacs, and drug abusers
G. Inchauspe, K. Abe, S. Zebedee, M. Nasoff, A. Prince (1991)
Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reactionHepatology, 14
K. Cristiano, A. Bisceglie, J. Hoofnagle, S. Feinstone (1991)
Hepatitis C viral RNA in serum of patients with chronic non‐A, non‐B hepatitis: Detection by the polymerase chain reaction using multiple primer setsHepatology, 14
H. Okamoto, Shunichi Okada, Yasushi Sugiyama, S. Yotsumoto, Takeshi Tanaka, H. Yoshizawa, F. Tsuda, Y. Miyakawa, M. Mayumi (1990)
The 5'-terminal sequence of the hepatitis C virus genome.The Japanese journal of experimental medicine, 60 3
P. Chomczyński, N. Sacchi (1987)
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Analytical biochemistry, 162 1
J. Garson, R. Tedder, M. Briggs, P. Tuke, J. Glazebrook, A. Trute, D. Parker, J. Barbara, Marcela Contreras, S. Aloysius (1990)
Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivityThe Lancet, 335
Finlayson Finlayson, Tankersley Tankersley (1990)
Anti‐HCV screening and plasma fractionation: the case against (letter; comment)Lancet, 335
R. Brettle (1985)
NON-A, NON-B HEPATITIS AND INTRAVENOUS IMMUNOGLOBULINThe Lancet, 325
J. Oncley, M. Melin (1949)
The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and beta1-lipoprotein into subfractions of human plasma.Journal of the American Chemical Society, 71 2
P. Simmonds, P. Balfe, J. Peutherer, C. Ludlam, J. Bishop, A. Brown (1990)
Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbersJournal of Virology, 64
J. Garson, P. Tuke, M. Makris, M. Briggs, S. Machin, F. Preston, R. Tedder (1990)
Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentratesThe Lancet, 336
J. Mosley, R. Aach, F. Hollinger, C. Stevens, L. Barbosa, G. Nemo, P. Holland, W. Bancroft, Hyman Zimmerman, G. Kuo, Q. Choo, M. Houghton (1990)
Non-A, non-B hepatitis and antibody to hepatitis C virus.JAMA, 263 1
J. Björkander, C. Cunningham-Rundles, P. Lundin, R. Olsson, R. Söderström, L. Hanson (1988)
Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency.The American journal of medicine, 84 1
Aach Rd, C. Stevens, Hollinger Fb, J. Mosley, D. Peterson, P. Taylor, R. Johnson, L. Barbosa, G. Nemo (1992)
Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.The New England journal of medicine, 325 19
H. Alter, R. Purcell, J. Shih, J. Melpolder, M. Houghton, Q. Choo, G. Kuo (1989)
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.The New England journal of medicine, 321 22
A. Lever, David Brown, A. Webster, H. Thomas (1984)
NON-A, NON-B HEPATITIS OCCURRING IN AGAMMAGLOBULINAEMIC PATIENTS AFTER INTRAVENOUS IMMUNOGLOBULINThe Lancet, 324
E. Cohn, L. Strong (1946)
Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.Journal of the American Chemical Society, 68
S. Feinstone, S. Feinstone, H. Alter, H. Alter, Hans Dienes, Hans Dienes, Yohko Shimizu, Yohko Shimizu, Hans Popper, Hans Popper, D. Blackmore, D. Blackmore, D. Sly, D. Sly, W. London, W. London, Robert Purcell, Robert Purcell (1981)
Non-A, non-B hepatitis in chimpanzees and marmosets.The Journal of infectious diseases, 144 6
J. Garson, F. Preston, M. Makris, P. Tuke, C. Ring, S. Machin, R. Tedder (1990)
Detection by PCR of hepatitis C virus in factor VIII concentratesThe Lancet, 335
J. Finlayson, D. Tankersley (1990)
Anti-HCV screening and plasma fractionation: the case againstThe Lancet, 335
Senior Staff Fellow, Division of Hematology, Ccnter for Biologics Evaluation and Research; current address: Genetic Therapy, Inc., 19 First Field Road
Q. Choo, G. Kuo, A. Weiner, L. Overby, D. Bradley, M. Houghton (1989)
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.Science, 244 4902
P. Williams, P. Yap, J. Gillon, R. Crawford, S. Urbaniak, G. Galea (1989)
Transmission of Non‐A, Non‐B Hepatitis by pH4‐Treated Intravenous ImmunoglobulinVox Sanguinis, 57
Because of concern about the safety of immune globulins with respect to transmission of hepatitis C, the partitioning of hepatitis C virus (HCV) during alcohol fractionation of a plasma pool prepared exclusively from anti‐HCV‐reactive donations was examined. Quantitation of HCV RNA was accomplished by nested polymerase chain reaction (PCR) at limiting dilutions. One PCR unit was arbitrarily defined as the minimum amount of HCV RNA from which an amplified product could be detected. The starting plasma pool contained 1.4 × 10(5) PCR units per mL. Most of the HCV RNA was found in cryoprecipitate and in Cohn fractions I and III, but it was also detected in fraction II, which is used for immunoglobulin G preparations. A 3.4‐percent solution of IgG prepared from this fraction II contained 30 PCR units per mL. The fractionation process leading to immune globulin resulted in overall reduction in HCV RNA by a factor of 4.7 × 10(4). Although the presence of HCV RNA in the final product does not necessarily imply the presence of infectious virus, this work suggests that the safety of immune globulins with respect to HCV transmission is not due solely to the partitioning of HCV away from the immunoglobulin fraction.
Transfusion – Wiley
Published: Nov 12, 1992
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.